Is neuromyelitis optica without AQP4-IgG a T-cell mediated disease? insights from checkpoint inhibitor immune-related adverse events
Salam Nasralla, Hesham Abboud
Topics & Concepts
Neuromyelitis opticaMedicineMultiple sclerosisAdverse effectImmunologyDiseaseAntibodyImmune systemInternal medicineMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersCNS Lymphoma Diagnosis and Treatment